维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

3篇 您的检索式：作者名="David Escors"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential显示文摘	David Escors Karine Breckpot	2010	Archivum Immunologiae et Therapiae Experimentalis2010，，2：	1
	2	DNA fusion vaccine designs to induce tumor‐lytic CD8+ T‐cell attack via the immunodominant cysteine‐containing epitope of NY‐ESO 1显示文摘	Juan Campos‐Perez Jason Rice David Escors Mary Collins Alex Paterson Natalia Savelyeva Freda K. Stevenson	2013	Int J Cancer2013，，6：	1
	3	The intracellular signalosome of PD-L1 in cancer cells显示文摘Programmed cell death-1 ligand-1(PD-L1)overexpression in cancer cells accelerates tumor progression.PD-L1 possesses two main pro-oncogenic functions.First,PD-L1 is a strong immunosuppressive molecule that inactivates tumor-specific T cells by binding to the inhibitory receptor PD-1.Second,PD-L1 function relies on the delivery of intrinsic intracellular signals that enhance cancer cell survival,regulate stress responses and confer resistance toward pro-apoptotic stimuli,such as interferons.Here,we review the current knowledge on intracellular signal transduction pathways regulated by PD-L1,describe its associated signalosome and discuss potential combinations of targeted therapies against the signalosome with PD-L1/PD-1 blockade therapies.	David Escors Maria Gato-Canas Miren Zuazo Hugo Arasanz María Jesus García-Granda Ruth Vera Grazyna Kochan	2018	Signal Transduction and Targeted Therapy2018，3，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费